Follow
A new study published in the journal Anti-inflammatory Nutraceuticals and Chronic Diseases, found that sanguinarine, a derivative of bloodroot, a wildflower found in North America, could combat multidrug-resistant tuberculosis (MRTB) after being genetically modified to reduce its natural toxicity.
The compound was not only able to suppress dormant TB bacteria from resurfacing but also didn’t damage the gut microbiome.
@nursefrombirth Still good news about the active, nontoxic version though
@nursefrombirth Thanks for posting this but I’m pretty sure the author of article doesn’t know what they are talking about. The term “genetically modified” makes no sense with regard to this compound and its analogs. The compound(s) (“regular” sanguinarine or an analog) might be biosynthesized by genetically manipulated yeast strains (not the same thing as the compound itself being genetically modified), or via classical chemistry techniques. Lazy reporting.